🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› EU
Clinical trial register · European Union · CTIS

Recently authorised EU trials

The most recently authorised trials on the EU Clinical Trials Information System (CTIS), the single register for every trial run under the EU Clinical Trials Regulation (536/2014). CTIS holds a far larger historical archive than any one list can usefully show — this register states both numbers rather than picking one.

Download CSV
Source: EMA Clinical Trials Information System (CTIS). Showing the 2500 most recently authorised of 12445 total CTIS records — a stated recency window, not the full historical archive. Synced 19 Sep 2026, 04:26 UTC
2500
Shown in this register
most recently authorised
12,445
Total on CTIS
full historical archive
745
Phase III
within the shown window
Top member states
Spain 1023 France 890 Germany 861 Italy 742 Poland 581 Netherlands 524
Narrow the registerReset
Phase
Phase I 558 Phase I/II 214 Phase II 726 Phase III 745 Phase IV 257
Lead sponsor
AstraZeneca AB 60 Assistance Publique Hopitaux De Paris 49 Merck Sharp & Dohme LLC 48 Pfizer Inc. 45 Novo Nordisk A/S 42
Member state
Spain 1023 France 890 Germany 861 Italy 742 Poland 581 Netherlands 524 Belgium 426 Czechia 327
All 28 states
257 of 2500 shown studies
Download
Phase
Study
Lead sponsor
Area
Member states
Decision
Phase IV
Multicentre, randomized, open label study comparing the concomitant administration of trabectedin and low-dose radiotherapy versus trabectedin alone in patients with advanced sarcoma
2026-525703-27-00Soft tissue sarcoma, osteosarcoma, or Ewing's sarcoma
Instituto De Investigacion Sanitaria Fundacion Jimenez Diaz
Musculoskeletal Diseases
Spain
18/09/2026
Phase IV
Antibiotic Prophylaxis in Hematopoietic Stem Cell Transplantation: a Randomised Controlled Trial - The ANTURA trial
2025-524982-25-00Hematologic malignancies treated with allogeneic hematopoie…
HUS-yhtymae
Hemic and Lymphatic Diseases
Finland
18/09/2026
Phase IV
Attachment Development and Learning in ADHD: The Role of Dopamine.
2025-525122-35-00Attention-Deficit/Hyperactivity Disorder (ADHD)
UZ Leuven
Mental Disorders
Belgium
15/09/2026
Phase IV
Effects of General Anaesthetic Agents on the Efficacy of Electroconvulsive Therapy and EEG Changes in Patients with Depression
2025-524829-40-00Severe unipolar depression treated with electroconvulsive t…
Varsinais-Suomen hyvinvointialue
Mental Disorders
Finland
15/09/2026
Phase IV
REconsidering Long-TErm ASpirin in the Elderly in Secondary Prevention of Coronary Artery Disease (RELEASE) Norway: A Randomised, Registry-based Trial
2026-526941-91-00Chronic coronary syndrome
Vestre Viken HF
Circulatory and Respiratory Physiological Phenomena
Norway
15/09/2026
Phase IV
A Rollover Study to Follow the Long-term Durability of Response to UGN-103 in Participants From Study BL013
2026-526359-75-00Non-Muscle Invasive Bladder Cancer
Urogen Pharma Ltd.
Neoplasms
Estonia, Romania, Spain, Bulgaria, Latvia
11/09/2026
Phase IV
AIRITY: A hybrid cross-sectional and prospective study to assess patient characteristics, disease burden, disease control, phenotypes, endotypes, and outcomes in a real-world setting in patients with asthma
2025-524916-13-00Asthma
Sanofi-Aventis Recherche & Developpement
Respiratory Tract Diseases
France, Spain, Germany, Italy
09/09/2026
Phase IV
Randomized study evaluating the impact of an innovative and cooperative pathway integrating oncogeriatric, pharmaceutical and pharmacological follow-up in elderly patients (>70 years old) presenting with cancer and treated with oral therapy _ POG
2025-523610-83-00Elderly patients (>70 years old) presenting with cancer and…
Institut Gustave Roussy
Immune System Diseases
France
08/09/2026
Phase IV
A double-blind, randomised, 30-week placebo-controlled phase IV study to assess the efficacy and safety of osilodrostat in patients with hypertension caused by hypercortisolaemia due to Cushing’s Syndrome
2025-524649-28-00Cushing's syndrome
Recordati AG
Hormonal diseases
Germany, Bulgaria, France, Romania, Italy, Poland, Spain
08/09/2026
Phase IV
POISON – Perioperative Safety and Effective Opioid Dosing in Chronic Opioid Use – a Randomized Clinical Study
2026-526719-13-00Opioid dependent chronic pain
Region Hovedstaden
Anesthesia and Analgesia
Denmark
08/09/2026
Phase IV
A Phase IV, open label, single arm trial to assess the safety and immunogenicity of BIMERVAX® XFG.1.1 against SARS-CoV-2 Omicron XFG.1.1 variant.
2026-527363-16-00COVID-19
Hipra Scientific S.L.
Virus Diseases
Spain
07/09/2026
Phase IV
ACTOR – AUC Control of Tacrolimus in Organ Recipients
2026-527107-22-00Kidney transplantation
Oslo Universitetssykehus HF
Therapeutics
Norway
02/09/2026
Phase IV
Reduced-dose versus full-dose systemic thrombolysis for high-risk pulmonary embolism: a multicentre, randomised, open-label, blinded-endpoint trial
2024-515904-37-00Pulmonary embolism
Vaestra Goetalandsregionen, University Of Gothenburg
Cardiovascular Diseases
Denmark, Sweden, Norway
02/09/2026
Phase IV
Optimization of Dupilumab Maintenance Dosing in Eosinophilic Esophagitis: A Phase IV, Randomized, Controlled, Single-Blind, Non-Inferiority Study
2026-526348-11-01Eosinophilic Esophagitis
Amsterdam UMC Stichting
Digestive System Diseases
Netherlands
01/09/2026
Phase IV
Incidence and severity of postoperative delirium associated with Dexmedetomidine sedation during femur osteosynthesis in the elderly population
2025-523070-16-00Postoperative delirium
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
Nervous System Diseases
Spain
31/08/2026
Phase IV
A prospective, randomized, double-blinded, placebo-controlled, cross-over study investigating the effects of metyrapone treatment on cardio-metabolic outcome parameters and chronobiology in patients with mild autonomous cortisol secretion
2026-526837-24-00Mild autonomous cortisol secretion
Medical University Of Vienna
Hormonal diseases
Austria
29/08/2026
Phase IV
A prospective, exploratory, parallel-group, low-intervention, phase IV, randomized, double-blind, placebo-controlled, multi-center, national, 2-arm trial to investigate efficacy and safety of Amara-Tropfen (Amara drops) in patients with irritable bowel syndrome (IBS)
2026-526668-19-00Irritable Bowel Syndrome
Weleda AG
Digestive System Diseases
Germany
28/08/2026
Phase IV
S-KETamine vs. propofol for prehospital sedation of patients with severe Acute Brain Injury: The KETABI randomised trial
2026-525588-41-00traumatic brain injury, subarachnoid haemorrhage, intracere…
Region Hovedstaden
Pathological Conditions, Signs and Symptoms
Denmark
27/08/2026
Phase IV
Piperacillin/tazobactam or ampicillin and gentamicin for empirical treatment of community acquired infection: A randomised clinical trial (PAGER)
2026-526131-20-00Urosepsis, Infection of unknown origin, Pyelonephritis, Cys…
Region Hovedstaden
Bacterial Infections and Mycoses
Denmark
25/08/2026
Phase IV
Adalimumab Treatment for Patients with Hidradenitis Suppurativa at high risk of Progressing to Severe Disease: An Unblinded Randomized, Controlled Trial
2025-522505-37-00Hidradenitis suppurativa
Gentofte Hospital
Skin and Connective Tissue Diseases
Denmark
24/08/2026
Phase IV
Effects of Menopausal Hormone Therapy on QTc in Genetically Confirmed Long QT Syndrome: A Prospective Randomized Sequential Crossover Study with Long-Term Observational Follow-Up (LQTS-HER)
2026-526442-28-00Long QT syndrome
Oslo Universitetssykehus HF
Cardiovascular Diseases
Norway
20/08/2026
Phase IV
An Open-Label Study to Investigate the Long-Term Effects of Acoramidis on Cardiac Function, Structure and Cardiac Amyloid Burden in Participants with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
2026-526068-19-00Transthyretin Amyloidosis
Eidos Therapeutics Inc.
Cardiovascular Diseases
Spain, Denmark
20/08/2026
Phase IV
Phase IV Low Intervention Clinical Trial to Study Biomarkers of "inflammageing" and Senescence in Pre-diabetic Patients Treated with Metformin: A Study nested within the project “NLRP3 Inflammasome at the Crossroad of Vascular Inflammageing: A Novel Target for Senomorphic Drugs”.
2026-527080-15-00Pre-diabetic Patients
Universidad Autonoma De Madrid
Metabolism
Spain
14/08/2026
Phase IV
A randomized, double blind, placebo-controlled study comparing the efficacy of dupilumab to standard of care (SOC) treatment following hospitalization for a COPD exacerbation
2025-524392-23-00Chronic obstructive pulmonary disease (COPD)
Regeneron Pharmaceuticals Inc.
Respiratory Tract Diseases
Belgium, Italy, Spain
13/08/2026
Phase IV
Patient-Controlled Anesthesia for endoscopic Procedural Sedation – PCAPS study
2025-524859-31-00Adenoma
Karolinska Institutet
Digestive System Diseases
Sweden
11/08/2026
Rows per page Showing 1–25 of 257
1 2 3 Next
Cite this view

Priya Life Science (2026). EU Clinical Trials Register (CTIS), filtered. Derived from the EMA Clinical Trials Information System. Retrieved 19 September 2026. https://priyalifescience.com/clinical-trials-europe

Query this register directly
GET /api/export.php?register=trials-eu&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. Looking for Irish sites? See the Ireland, UK or USA registers. For approved medicines, see the EMA Approvals Tracker.